APOE and fatty liver disease: In the present work, we have shown that a known autophagy inducer—trehalose—given orally for a 16-week period and without any visible adverse effects, inhibited atherosclerosis and attenuated hepatic steatosis in apoE−/− mice fed with a chow and a high-fat diet, respectively.